EnGeneIC Wins Innovation Award from Australian Financial Review

August 09, 2019   |   August 2019 Bond Updates
NEW YORK and SYDNEY, Aug. 9, 2019 /PRNewswire/ -- EnGeneIC Limited, a clinical-stage biopharmaceutical company advancing its proprietary EDV™ nanocell platform for targeted cyto-immunotherapy in cancer, was named the most innovative company in the category of healthcare for 2019 by The...

View more at: https://www.prnewswire.com:443/news-releases/engeneic-wins-innovation-award-from-australian-financial-review-300899312.html
 
Related News
Home| About us | Contact us http://www.bondupdatesdailynews.com/